About Strategikon Pharma
Strategikon Pharma is a private company based in San Francisco, California. It has reported $2,291,885 raised in three offerings on Form D since November 2017. Its chief executive is Anca Copaescu.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 8, 2025 | Nov 21, 2025 | $2,291,885of $3.0M target | 15 | $152K | DebtRule 506(b) | Form D ↗ |
| Not yet | Apr 6, 2018 | $0target not set | 0 | — | Equity, Options, Securities on exerciseRule 504, Rule 506(b) | Form D ↗ |
| Not yet | Nov 15, 2017 | $0of $1.0M target | 0 | — | Equity, Debt, Options, Securities on exerciseRule 504, Rule 506(b) | Form D ↗ |
| Total, three offerings | $2,291,885 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Strategikon Pharma's Form D filed Nov 21, 2025.
RH
Rob Hess
Director
AC
Anca Copaescu
Chief Executive Officer and director
DA
Debra Apruzzese
Director
CC
Chris Codeanne
Director
PC
Paulo Carvalho
Executive officer
VL
Vincent Lepreux
Director
MW
Mark Weinstein
Executive officer and director
NL
Nathanael Lentz
Director
Earlier filings also listed Mark Di Ianni (secretary and director, last listed Apr 2018).